VANGUARD GROUP INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$12,785,000
+73.0%
2,767,268
+31.0%
0.00%
Q4 2018$7,392,000
-72.4%
2,112,007
-20.6%
0.00%
-100.0%
Q3 2018$26,825,000
+45.8%
2,661,324
+4.7%
0.00%0.0%
Q2 2018$18,401,000
+27.5%
2,541,548
+6.3%
0.00%0.0%
Q1 2018$14,435,000
-40.9%
2,390,002
-5.8%
0.00%0.0%
Q4 2017$24,407,000
+19.9%
2,537,086
+10.7%
0.00%0.0%
Q3 2017$20,354,000
-31.0%
2,292,107
-1.8%
0.00%0.0%
Q2 2017$29,516,000
+19.4%
2,333,254
-0.8%
0.00%0.0%
Q1 2017$24,711,000
+12.8%
2,351,107
-1.3%
0.00%0.0%
Q4 2016$21,904,000
-22.0%
2,380,892
-0.1%
0.00%
-50.0%
Q3 2016$28,092,000
-9.0%
2,382,704
-0.1%
0.00%0.0%
Q2 2016$30,859,000
-22.6%
2,384,781
-4.3%
0.00%
-33.3%
Q1 2016$39,847,000
-38.8%
2,491,995
+9.5%
0.00%
-25.0%
Q4 2015$65,151,000
-38.5%
2,275,622
-38.9%
0.00%0.0%
Q3 2015$105,930,000
+63.8%
3,722,082
+106.8%
0.00%0.0%
Q2 2015$64,652,000
+29.1%
1,799,892
+108.9%
0.00%
+33.3%
Q1 2015$50,086,000
+89.5%
861,615
+37.4%
0.00%
+50.0%
Q4 2014$26,436,000
+5.4%
627,047
-3.0%
0.00%0.0%
Q3 2014$25,070,000
+62.7%
646,452
+31.0%
0.00%
+100.0%
Q2 2014$15,408,000
-22.4%
493,389
+2.9%
0.00%
-50.0%
Q1 2014$19,863,000
+300.5%
479,437
+274.1%
0.00%
Q4 2013$4,960,000
+57.0%
128,148
+41.9%
0.00%
Q3 2013$3,159,000
+173.5%
90,286
+8.1%
0.00%
Q2 2013$1,155,00083,5090.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders